174 related articles for article (PubMed ID: 11899380)
1. Results and implications of the Royal Marsden and other tamoxifen chemoprevention trials.
Ross PJ; Powles TJ
Clin Breast Cancer; 2001 Apr; 2(1):33-6; discussion 37-40. PubMed ID: 11899380
[TBL] [Abstract][Full Text] [Related]
2. Results and implications of the Royal Marsden and other tamoxifen chemoprevention trials: an alternative view.
Costantino JP; Vogel VG
Clin Breast Cancer; 2001 Apr; 2(1):41-6. PubMed ID: 11899381
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer prevention.
Powles TJ
Oncologist; 2002; 7(1):60-4. PubMed ID: 11854547
[TBL] [Abstract][Full Text] [Related]
4. The Royal Marsden Hospital (RMH) trial: key points and remaining questions.
Powles TJ
Ann N Y Acad Sci; 2001 Dec; 949():109-12. PubMed ID: 11795342
[TBL] [Abstract][Full Text] [Related]
5. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial.
Powles T; Eeles R; Ashley S; Easton D; Chang J; Dowsett M; Tidy A; Viggers J; Davey J
Lancet; 1998 Jul; 352(9122):98-101. PubMed ID: 9672274
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of breast cancer.
Dalton RR; Kallab AM
South Med J; 2001 Jan; 94(1):7-15. PubMed ID: 11213947
[TBL] [Abstract][Full Text] [Related]
7. Update on breast cancer prevention.
Rastogi P; Vogel VG
Oncology (Williston Park); 2003 Jun; 17(6):799-805; discussion 808-10, 813. PubMed ID: 12846124
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer prevention trials.
Rhodes DJ; Hartmann LC; Perez EA
Curr Oncol Rep; 2000 Nov; 2(6):558-65. PubMed ID: 11122893
[TBL] [Abstract][Full Text] [Related]
9. Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts.
Vogel VG
Clin Cancer Res; 2001 Dec; 7(12 Suppl):4413s-4418s; discussion 4411s-4412s. PubMed ID: 11916233
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention of breast cancer with tamoxifen.
Cuzick J
IARC Sci Publ; 1996; (136):95-109. PubMed ID: 8791120
[No Abstract] [Full Text] [Related]
11. Should women be advised to take prophylactic endocrine treatment outside of a clinical trial setting?
Gogas H; Markopoulos C; Blamey R
Ann Oncol; 2005 Dec; 16(12):1861-6. PubMed ID: 15980159
[TBL] [Abstract][Full Text] [Related]
12. [Chemoprevention of breast cancer: a hope justified?].
Buser K; Delaloye JF
Rev Med Suisse Romande; 2000 Jun; 120(6):511-3. PubMed ID: 11014095
[TBL] [Abstract][Full Text] [Related]
13. Prevention of breast cancer in high-risk women.
Kardinal CG; Veith R
J La State Med Soc; 1999 Apr; 151(4):198-201. PubMed ID: 10234895
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of breast cancer.
Brown PH; Lippman SM
Breast Cancer Res Treat; 2000 Jul; 62(1):1-17. PubMed ID: 10989982
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer chemoprevention: risk-benefit effects of the antioestrogen tamoxifen.
Brown K
Expert Opin Drug Saf; 2002 Sep; 1(3):253-67. PubMed ID: 12904141
[TBL] [Abstract][Full Text] [Related]
16. Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial.
Powles TJ; Ashley S; Tidy A; Smith IE; Dowsett M
J Natl Cancer Inst; 2007 Feb; 99(4):283-90. PubMed ID: 17312305
[TBL] [Abstract][Full Text] [Related]
17. Status of antiestrogen breast cancer prevention trials.
Powles TJ
Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):28-31. PubMed ID: 9556788
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer prevention: present and future.
Salih AK; Fentiman IS
Cancer Treat Rev; 2001 Oct; 27(5):261-73. PubMed ID: 11871862
[TBL] [Abstract][Full Text] [Related]
19. BRCA1/BRCA2 mutation status and analysis of cancer family history in participants of the Royal Marsden Hospital tamoxifen chemoprevention trial.
Kote-Jarai Z; Powles TJ; Mitchell G; Tidy A; Ashley S; Easton D; Assersohn L; Sodha N; Salter J; Gusterson B; Dowsett M; Eeles R
Cancer Lett; 2007 Mar; 247(2):259-65. PubMed ID: 16777318
[TBL] [Abstract][Full Text] [Related]
20. Phase III, large-scale chemoprevention trials. Approach to chemoprevention clinical trials and phase III clinical trial of tamoxifen as a chemopreventive for breast cancer--the US National Cancer Institute experience.
Dunn BK; Kramer BS; Ford LG
Hematol Oncol Clin North Am; 1998 Oct; 12(5):1019-36, vii. PubMed ID: 9888019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
